Related references
Note: Only part of the references are listed.Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers
Silvia Cantoni et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Long-term results of splenectomy in adult chronic immune thrombocytopenia
Yue Guan et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2017)
A large observational study of patients with primary immune thrombocytopenia receiving romiplostim in European clinical practice
Michael Steurer et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2017)
Diagnosis and management of immune thrombocytopenia in childhood
Thomas Kuehne
HAMOSTASEOLOGIE (2017)
Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long-term response
Miriam Marangon et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2017)
Risk of cardiovascular events and pulmonary hypertension following splenectomy - a Danish population-based cohort study from 1996-2012
Marianne Rorholt et al.
HAEMATOLOGICA (2017)
Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia
Douglas B. Cines et al.
HAEMATOLOGICA (2017)
US Food and Drug Administration approval summary: Eltrombopag for the treatment of pediatric patients with chronic immune (idiopathic) thrombocytopenia
Lori A. Ehrlich et al.
PEDIATRIC BLOOD & CANCER (2017)
Epidemiology and management of primary immune thrombocytopenia: A nationwide population-based study in Korea
Ji Yun Lee et al.
THROMBOSIS RESEARCH (2017)
Risk of cardiovascular events and pulmonary hypertension following splenectomy - a Danish population-based cohort study from 1996-2012
Marianne Rorholt et al.
HAEMATOLOGICA (2017)
Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia
Douglas B. Cines et al.
HAEMATOLOGICA (2017)
Postnatal innate immune Development: From Birth to Adulthood
Anastasia Georgountzou et al.
FRONTIERS IN IMMUNOLOGY (2017)
Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)
Anne Zufferey et al.
JOURNAL OF CLINICAL MEDICINE (2017)
Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study
Raymond S. M. Wong et al.
BLOOD (2017)
Beyond immune thrombocytopenia: the evolving role of thrombopoietin receptor agonists
Francesco Rodeghiero et al.
ANNALS OF HEMATOLOGY (2017)
Clinical updates in adult immune thrombocytopenia
Michele P. Lambert et al.
BLOOD (2017)
Is ITP a thrombophilic disorder?
Francesco Rodeghiero
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study
Adrian Newland et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Clinical Outcome and Predictive Factors in the Response to Splenectomy in Elderly Patients with Primary Immune Thrombocytopenia: A Multicenter Retrospective Study
Young Hoon Park et al.
ACTA HAEMATOLOGICA (2016)
Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia
Ann Janssens et al.
ANNALS OF HEMATOLOGY (2016)
Real-life management of primary immune thrombocytopenia (ITP) in adult patients and adherence to practice guidelines
Maria Luisa Lozano et al.
ANNALS OF HEMATOLOGY (2016)
Long-term outcome following splenectomy for chronic and persistent immune thrombocytopenia (ITP) in adults and children
Rayaz Ahmed et al.
ANNALS OF HEMATOLOGY (2016)
Blind men and the refractory ITP elephant
Shruti Chaturvedi et al.
BLOOD (2016)
Immune thrombocytopenia in adults: a prospective cohort study of clinical features and predictors of outcome
Lamiae Grimaldi-Bensouda et al.
HAEMATOLOGICA (2016)
Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study
Michael D. Tarantino et al.
LANCET (2016)
Long-term complications of splenectomy in adult immune thrombocytopenia
Lan-Huong Thai et al.
MEDICINE (2016)
Thrombopoietin Receptor Agonist Use in Children: Data From the Pediatric ITP Consortium of North America ICON2 Study
Cindy Neunert et al.
PEDIATRIC BLOOD & CANCER (2016)
Thrombopoietin Receptor Agonists Are Often Ineffective in Immune Thrombocytopenia and/or Cause Adverse Reactions: Results from One Hand
Fabian Depre et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2016)
Immune thrombocytopenia in adults: a prospective cohort study of clinical features and predictors of outcome
Lamiae Grimaldi-Bensouda et al.
HAEMATOLOGICA (2016)
Sialidase inhibition to increase platelet counts: A new treatment option for thrombocytopenia
Arend Jan Gerard Jansen et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia
Tomas Jose Gonzalez-Lopez et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged ≥65 years with immune thrombocytopenia
Marc Michel et al.
ANNALS OF HEMATOLOGY (2015)
Platelet function tests, independent of platelet count, are associated with bleeding severity in ITP
Andrew L. Frelinger et al.
BLOOD (2015)
Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review
C. Neunert et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial
Waleed Ghanima et al.
LANCET (2015)
Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial
John D. Grainger et al.
LANCET (2015)
Treatment of Immune Thrombocytopenia in Adults: The Role of Thrombopoietin-Receptor Agonists
Francesco Rodeghiero et al.
SEMINARS IN HEMATOLOGY (2015)
Can Immune Thrombocytopenia Be Cured with Medical Therapy?
Adam Cuker et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2015)
Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis
Shaan Chugh et al.
LANCET HAEMATOLOGY (2015)
Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled study
James B. Bussel et al.
LANCET HAEMATOLOGY (2015)
The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling
Renata Grozovsky et al.
NATURE MEDICINE (2015)
Does the site of platelet sequestration predict the response to splenectomy in adult patients with immune thrombocytopenic purpura?
Julie Navez et al.
PLATELETS (2015)
Rituximab versus splenectomy in persistent or chronic adult primary immune thrombocytopenia: an adjusted comparison of mortality and morbidity
Guillaume Moulis et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Conflicts of Interest and Clinical Recommendations: Comparison of Two Concurrent Clinical Practice Guidelines for Primary Immune Thrombocytopenia Developed by Different Methods
James N. George et al.
AMERICAN JOURNAL OF MEDICAL QUALITY (2014)
Five hematologic tests and treatments to question
Lisa K. Hicks et al.
BLOOD (2014)
Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients
Mehdi Khellaf et al.
BLOOD (2014)
Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France
Guillaume Moulis et al.
BLOOD (2014)
A review of the management of childhood immune thrombocytopenia: how can we provide an evidence-based approach?
Nichola Cooper
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Rituximab and three dexamethasone cycles provide responses similar to splenectomy in women and those with immune thrombocytopenia of less than two years duration
James B. Bussel et al.
HAEMATOLOGICA (2014)
Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors
M. Ruggeri et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
A Novel Method for Laparoscopic Splenectomy in the Setting of Hypersplenism Secondary to Liver Cirrhosis: Ten Years' Experience
Yunqiang Cai et al.
WORLD JOURNAL OF SURGERY (2014)
Laparoscopic splenectomy for medically refractory immune thrombocytopenia (ITP): A retrospective cohort study on longtime response predicting factors based on consensus criteria
Emile Rijcken et al.
INTERNATIONAL JOURNAL OF SURGERY (2014)
Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia
Soames Boyle et al.
BLOOD (2013)
The effect of rituximab on vaccine responses in patients with immune thrombocytopenia
Ishac Nazi et al.
BLOOD (2013)
Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group
Francesco Rodeghiero et al.
BLOOD (2013)
Outcomes of splenectomy in patients with common variable immunodeficiency (CVID): a survey of 45 patients
G. K. Wong et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Safety and efficacy of splenectomy in over 65-yrs-old patients with immune thrombocytopenia
Jose R. Gonzalez-Porras et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2013)
Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years
Nicola Vianelli et al.
HAEMATOLOGICA (2013)
B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells
Matthieu Mahevas et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Duration and morbidity of chronic immune thrombocytopenic purpura in children: five-year follow-up of a Nordic cohort
Steen Rosthoj et al.
ACTA PAEDIATRICA (2012)
Increased number of B-cells in the red pulp of the spleen in ITP
Bob Olsson et al.
ANNALS OF HEMATOLOGY (2012)
Splenic proliferative lymphoid nodules distinct from germinal centers are sites of autoantigen stimulation in immune thrombocytopenia
Capucine Daridon et al.
BLOOD (2012)
How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment
Waleed Ghanima et al.
BLOOD (2012)
Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia
Vivek L. Patel et al.
BLOOD (2012)
Short- and long-term risks of splenectomy for benign haematological disorders: should we revisit the indications?
Francesco Rodeghiero et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Rituximab for Children with Immune Thrombocytopenia: A Systematic Review
Yi Liang et al.
PLOS ONE (2012)
The scintigraphic index spleen/liver at 30 minutes predicts the success of splenectomy in persistent and chronic primary immune thrombocytopenia
Manel Roca et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Pregnancy outcomes after maternal exposure to rituximab
Eliza F. Chakravarty et al.
BLOOD (2011)
Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program
Mehdi Khellaf et al.
BLOOD (2011)
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
Cindy Neunert et al.
BLOOD (2011)
Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients
Delphine Gobert et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
International consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan et al.
BLOOD (2010)
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia
Francesco Zaja et al.
BLOOD (2010)
Autologous 111In-labelled platelet sequestration studies in patients with primary immune thrombocytopenia (ITP) prior to splenectomy: a report from the United Kingdom ITP Registry
Ameet Sarpatwari et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Mortality risk in splenectomised patients: A Danish population-based cohort study
Mellissa Yong et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2010)
Short-term and long-term failure of laparoscopic splenectomy in adult immune thrombocytopenic purpura patients: A systematic review
Joseph Mikhael et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Risk for Hospital Contact With Infection in Patients With Splenectomy A Population-Based Cohort Study
Reimar W. Thomsen et al.
ANNALS OF INTERNAL MEDICINE (2009)
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
Francesco Rodeghiero et al.
BLOOD (2009)
The ITP syndrome: pathogenic and clinical diversity
Douglas B. Cines et al.
BLOOD (2009)
Repeated courses of rituximab for autoimmune cytopenias may precipitate profound hypogammaglobulinaemia requiring replacement intravenous immunoglobulin
Nichola Cooper et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Role of the spleen in peripheral memory B-cell homeostasis in patients with autoimmune thrombocytopenia purpura
Lorena Martinez-Gamboa et al.
CLINICAL IMMUNOLOGY (2009)
Is splenectomy still the gold standard for the treatment of chronic ITP?
Francesco Rodeghiero et al.
AMERICAN JOURNAL OF HEMATOLOGY (2008)
Splenectomy for immune thrombocytopenic purpura: Surgery for the 21st century
James P. Dolan et al.
AMERICAN JOURNAL OF HEMATOLOGY (2008)
The postoperative splenic/portal vein thrombosis after splenectomy and its prevention - an unresolved issue
Maria-Theresa Krauth et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Splenectomy in children with idiopathic thrombocytopenic purpura:: A prospective study of 134 children from the Intercontinental Childhood ITP Study Group
Thomas Kuehne et al.
PEDIATRIC BLOOD & CANCER (2007)
Systematic review: Efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura
Donald M. Arnold et al.
ANNALS OF INTERNAL MEDICINE (2007)
Evaluation of severe infection and survival after splenectomy
MH Kyaw et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Splenectomy and chronic thromboembolic pulmonary hypertension
X Jaïs et al.
THORAX (2005)
Analysis of outcome of laparoscopic splenectomy for idiopathic thrombocytopenic purpura by platelet count
A Keidar et al.
AMERICAN JOURNAL OF HEMATOLOGY (2005)
Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy - A systematic review
SK Vesely et al.
ANNALS OF INTERNAL MEDICINE (2004)
Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications
K Kojouri et al.
BLOOD (2004)
T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura
B Olsson et al.
NATURE MEDICINE (2003)
Vascular dementia in patients with immune thrombocytopenic purpura
YS Ahn et al.
THROMBOSIS RESEARCH (2002)
Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen
JM Davies et al.
CLINICAL MEDICINE (2002)
Spleen is a primary site for activation of platelet-reactive T and B cells in patients with immune thrombocytopenic purpura
M Kuwana et al.
JOURNAL OF IMMUNOLOGY (2002)
Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura:: a randomised, multicentre trial
B Godeau et al.
LANCET (2002)
Newly diagnosed idiopathic thrombocytopenic purpura in childhood:: an observational study
T Kühne et al.
LANCET (2001)
Risk of infection and death among post-splenectomy patients
N Bisharat et al.
JOURNAL OF INFECTION (2001)
Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura
R Stasi et al.
BLOOD (2001)
Morbidity and mortality in adults with idiopathic thrombocytopenic purpura
JEA Portielje et al.
BLOOD (2001)
Share Paper
